Results 41 to 50 of about 1,844,871 (401)

Activity Theory Analysis of Heart Failure Self-Care [PDF]

, 2017
The management of chronic health conditions such as heart failure is a complex process emerging from the activity of a network of individuals and artifacts.
Cornet, Victor, Holden, Richard J., Voida, Stephen   +2 more
core   +1 more source

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

European Heart Journal, 2005
ESC Committee for Practice Guidelines (CPG), Silvia G. Priori (Chairperson) (Italy), Jean-Jacques Blanc (France), Andrzej Budaj (Poland), John Camm (UK), Veronica Dean (France), Jaap Deckers (The Netherlands), Kenneth Dickstein (Norway), John Lekakis ...
K. Swedberg, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. Smiseth, A. Gavazzi, A. Haverich, A. Hoes, T. Jaarsma, J. Korewicki, Samuel Lévy, C. Linde, J. López-Sendón, M. Nieminen, L. Pierard, W. Remme   +18 more
semanticscholar   +1 more source

The interpretation of brain natriuretic peptide in critical care patients; will it ever be useful? [PDF]

, 2010
The measurement of B-type natriuretic peptide (BNP) is recommended for the diagnosis of decompensated heart failure, the prognosis of chronic heart failure is worse if BNP is increased and studies suggest that BNP is useful to guide therapy.
Dixon, J, Philips, B
core   +2 more sources

Transcultural adaptation and validation of the patient empowerment in long-term conditions questionnaire

BMC Health Services Research, 2017
Background Patient empowerment is a key element to improve the results in health, increase satisfaction amongst users and obtain higher treatment compliance.
Paloma Garcimartin, Josep Comin-Colet, Pilar Delgado-Hito, Neus Badosa-Marcé, Anna Linas-Alonso   +4 more
doaj   +1 more source

Phosphoproteomic and proteomic profiling in post-infarction chronic heart failure

Frontiers in Pharmacology, 2023
Background: Post-infarction chronic heart failure is the most common type of heart failure. Patients with chronic heart failure show elevated morbidity and mortality with limited evidence-based therapies.
Jiayue Wang, Xiuhua Zhu, Shenrui Wang, Yingjie Zhang, Wenjie Hua, Zhenyu Liu, Yu Zheng, Xiao Lu   +7 more
doaj   +1 more source

Heart Failure Monitoring System Based on Wearable and Information Technologies [PDF]

, 2007
In Europe, Cardiovascular Diseases (CVD) are the leading source of death, causing 45% of all deceases. Besides, Heart Failure, the paradigm of CVD, mainly affects people older than 65.
Arredondo Waldmeyer, Maria Teresa, Hoyo Barbolla, Eva del, Ottaviano, Manuel, Salvi, Dario, Villalba Mora, Elena   +4 more
core   +2 more sources

Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

Journal of Nihon University Medical Association, 2020
In 2018, The Japanese Circulation Society and The Japanese Heart Failure Society updated the Guidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure. I provide a summary of these new guidelines.

semanticscholar   +1 more source

ST2 and Multimarker Testing in Acute Decompensated Heart Failure [PDF]

, 2015
Most data on heart failure biomarkers have been derived from patient cohorts with chronic disease. However, risk prediction in patients admitted with acute decompensated heart failure (ADHF) remains a challenge.
Antoni, Md, Bayes, Genis, DI SOMMA, Salvatore, Maisel, Alan S., Md,, Md,, Md,, Mebazaa, Alexandre   +7 more
core   +1 more source

Time-Course Transcriptome Analysis for Drug Repositioning in Fusobacterium nucleatum-Infected Human Gingival Fibroblasts

Frontiers in Cell and Developmental Biology, 2019
Fusobacterium nucleatum (F. nucleatum) is a crucial periodontal pathogen and human gingival fibroblasts (GFs) are the first line of defense against oral pathogens.
Wenyan Kang, Wenyan Kang, Zhilong Jia, Zhilong Jia, Di Tang, Xiaojing Zhao, Xiaojing Zhao, Jinlong Shi, Qian Jia, Qian Jia, Kunlun He, Kunlun He, Qiang Feng, Qiang Feng   +13 more
doaj   +1 more source

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

European Heart Journal, 2020
Aims Cardiac miR-132 activation leads to adverse remodelling and pathological hypertrophy. CDR132L is a synthetic lead-optimized oligonucleotide inhibitor with proven preclinical efficacy and safety in heart failure (HF) early after myocardial infarction
S. Batkai, Celina Genschel, J. Viereck, S. Rump, C. Bär, T. Borchert, Denise Traxler, M. Riesenhuber, A. Spannbauer, D. Lukovic, K. Zlabinger, E. Hasimbegovic, Johannes Winkler, R. Garamvölgyi, Sonja Neitzel, M. Gyöngyösi, T. Thum   +16 more
semanticscholar   +1 more source